Conceptio
›
acute-myeloid-leukemia
Topic
acute-myeloid-leukemia
Knowledge-graph topic
· documents ABOUT acute-myeloid-leukemia across the archive
438
Documents about acute-myeloid-leukemia
Documents about acute-myeloid-leukemia
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
#829019
ClinicalTrials.gov
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT
#842829
ClinicalTrials.gov
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
#854688
ClinicalTrials.gov
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
#886213
ClinicalTrials.gov
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
#909929
ClinicalTrials.gov
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
#913238
ClinicalTrials.gov
CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial
#226247
ClinicalTrials.gov
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
#832648
ClinicalTrials.gov
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
#902112
ClinicalTrials.gov
Budget Impact of Venetoclax for Newly Diagnosed Patients with Acute Myeloid Leukemia Aged ≥ 75 Years or with Comorbidities Precluding Intensive Chemotherapy in the United States.
#170779
NCBI PubMed Central
Haplo HCT vs Haplo-cord HCT for Patients With AML
#839801
ClinicalTrials.gov
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia
#842590
ClinicalTrials.gov
Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy
#843300
ClinicalTrials.gov
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
#892335
ClinicalTrials.gov
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
#877747
ClinicalTrials.gov
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
#864987
ClinicalTrials.gov
A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML
#800773
ClinicalTrials.gov
Multi-omics integration of molecular genetics, cytogenetics and immunophenotyping: a novel prognostic model for immune landscape characterization and outcome prediction in Chinese patients with acute myeloid leukemia.
#199126
NCBI PubMed Central
Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation
#637000
PLOS
Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia
#805796
ClinicalTrials.gov
A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients
#828216
ClinicalTrials.gov
Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy
#854933
ClinicalTrials.gov
Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia
#1044331
ClinicalTrials.gov
Relapse vs Diagnosis in BEAT‑AML (Tyner et al., 2018; PMID: 30333627) : A Reproducible Single‑Block Workflow Demonstrating Proof‑of‑Principle for DRA
#632397
Zenodo (CERN)
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
#842294
ClinicalTrials.gov
Modeling, Analysis, and Optimal Control of Leukemic Cell Population Dynamics Under Therapy
#330181
HAL (France)
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
#981309
ClinicalTrials.gov
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
#827319
ClinicalTrials.gov
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
#861290
ClinicalTrials.gov
Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care
#826039
ClinicalTrials.gov
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
#862458
ClinicalTrials.gov
Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML
#992785
ClinicalTrials.gov
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
#908421
ClinicalTrials.gov
Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort
#250332
HAL (France)
Transcriptional and functional profiling reveals unique activation of Adapter CAR T cells in acute myeloid leukemia / Nele Knelangen, Ulrika Bader, Evangelia Maniaki, Boris Engels, Luca Gattinoni, Jörg Mittelstät
#784006
Deutsche Nationalbibliothek
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
#807681
ClinicalTrials.gov
Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells
#841573
ClinicalTrials.gov
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma
#844459
ClinicalTrials.gov
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
#848438
ClinicalTrials.gov
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
#852972
ClinicalTrials.gov
RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
#842446
ClinicalTrials.gov
Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes
#916402
ClinicalTrials.gov
Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
#828690
ClinicalTrials.gov
Palifermin After Haploidentical PBSCT
#864654
ClinicalTrials.gov
Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations
#893818
ClinicalTrials.gov
10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1
#914456
ClinicalTrials.gov
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
#357122
Gestión del Repositorio Documental de la Universidad de Salamanca
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
#803347
ClinicalTrials.gov
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
#805677
ClinicalTrials.gov
Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP)
#847325
ClinicalTrials.gov
← Previous
Page 18 of 19
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.